-
Study aim
-
Comparing the effects and side effects of two drugs, Dysport and Masport
-
Design
-
A clinical trial with 2 random groups, Masport and Dysport, double-blind, randomized, phase 2 on 160 patients.
-
Settings and conduct
-
This study will be conducted in the oculoplastic clinic of Farabi Hospital in Tehran, Iran. The study will be conducted in a double-blind manner, and none of the doctors and patients will know the type of injected drug. Before and after the injection, the questionnaire is completed by the patients and the relevant doctor. Before and after the injection, the faces of the patients are photographed while laughing, frowning, and indifference. The patients are followed up at intervals of 2 weeks, 2 months, and 4 months after the injection.
-
Participants/Inclusion and exclusion criteria
-
1-Physical and mental health of the participants
2- Decision-making power and completely voluntary participation in the study
3- Allowed age range 27-57
4- Confirmation of the need for injection by the doctor and the candidate for Botox injection
5-Candidates for oculoplasties
-
Intervention groups
-
Patients in two intervention groups are included in the study, 80 people will be injected with masport drug and 80 people will be injected with dysport drug. The study was double-blind and none of the patients and related doctors knew about the type of medicine.
-
Main outcome variables
-
1- Investigating the effect of two drugs in the same doses in removing and reducing the depth of wrinkles in patients
2- Examining the short-acting and long-acting side effects of both drugs, including inflammation, redness, and drooping of the eyelids.
3- Checking the shelf life of two drugs
4- Checking the need for re-injection and restoration of two drugs at intervals of 2 weeks, 2 months and 4 months